ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Dihydroxyflavones as potential therapeutic agents against inflammation and renal injury via p38 MAP kinase inhibition: an in silico and experimental study.
Farwa Naqvi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.